Abstract
The first cases of coccidioidomycosis in North America were reported by Rixford and Gilchrist (1896) and the clinical profiles of these cases delineated the variations that can occur during the course of developing disseminated disease. The first patient, Joas Furtado Silverra, exhibited a slowly progressing disease, primarily manifested with disfiguring skin lesions. In contrast, the second patient, José Teixera Pereira, presented in August of 1894 and succumbed after 2 months of a rapidly progressive illness. Because of variations of clinical progression and the histopathological responses between these two cases, the name Coccidioides (like coccidia) immitis (not mild) and Coccidioides pyogenes (generating suppuration) were assigned to this organism. While the organism was thought to be a protozoan, it was not until 1900 that William Ophuls correctly classified the organism as a fungus (Ophuls and Moffitt 1900).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ampel NM (1994) In vitro production of tumor necrosis factor-alpha by adherent human peripheral blood mononuclear cells incubated with killed coccidioidal arthroconidia and spherules. Cell Immunol 153:248–255
Ampel NM, Christian L (1997) In vitro modulation of proliferation and cytokine production by human peripheral blood mononuclear cells from subjects with various forms of coccidioidomycosis. Infect Immun 65:4483–4487
Ampel NM, Bejarano GC, Galgiani JN (1992) Killing of Coccidioides immitis by human peripheral blood mononuclear cells. Infect Immun 60:4200–4204
Ampel NM, Kramer LA, Kerekes KM, Johnson SM, Pappagianis D (2001) Assessment of the human cellular immune response to T27 K, a coccidioidal antigen preparation, by flow cytometry of whole blood. Med Mycol 39:315–320
Barnato AE, Sanders GD, Owens DK (2001) Cost-effectiveness of a potential vaccine for Coccidioides immitis. Emerg Infect Dis 7:797–806
Beaman L (1987) Fungicidal activation of murine macrophages by recombinant gamma interferon. Infect Immun 55:2951–2955
Beaman L (1991) Effects of recombinant gamma interferon and tumor necrosis factor on in vitro interactions of human mononuclear phagocytes with Coccidioides immitis. Infect Immun 59:4227–4229
Beaman L, Holmberg CA (1980) In vitro response of alveolar macrophages to infection with Coccidioides immitis. Infect Immun 28:594–600
Beaman L, Pappagianis D, Benjamini E (1977) Significance of T cells in resistance to experimental murine coccidioidomycosis. Infect Immun 17:580–585
Beaman L, Pappagianis D, Benjamini E (1979) Mechanisms of resistance to infection with Coccidioides immitis in mice. Infect Immun 23:681–685
Beaman L, Benjamini E, Pappagianis D (1981) Role of lymphocytes in macrophage-induced killing of Coccidioides immitis in vitro. Infect Immun 34:347–353
Beaman L, Benjamini E, Pappagianis D (1983) Activation of macrophages by lymphokines: enhancement of phagosome-lysosome fusion and killing of Coccidioides immitis. Infect Immun 39:1201–1207
Burt A, Carter DA, Koenig GL, White TJ, Taylor JW (1996) Molecular markers reveal cryptic sex in the human pathogen Coccidioides immitis. Proc Natl Acad Sci USA 93:770–773
Castleberry MW, Converse JL, Soto PJ Jr (1964) Antibiotic control of tissue reactions in dogs vaccinated with viable cells of Coccidioides immitis. J Bacteriol 87: 1216–1220
Castleberry MW, Converse JL, Sinski JT, Lowe EP, Pakes SP, Del Favero JE (1965) Coccidioidomycosis: studies of canine vaccination and therapy. J Infect Dis 115:41–48
CDC (1996) Coccidioidomycosis-Arizona, 1990–1995. MMWR Morb Mortal Wkly Rep 45:1069–1073
CDC (2003) Increase in coccidioidomycosis-Arizona, 1998–2001 MMWR Morb Mortal Wkly Rep 52:109–112
Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV (1997) CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 186:1623–1631
Cole GT (1997) Ammonia production by Coccidioides immitis and its possible significance to the hostfungus interplay. In: Bossche H, Stevens DA, Odds FC (eds) Host-fungus interplay. National Foundation for Infectious Disease, Bethesda, pp 247–263
Cole GT, Sun SH (1985) Arthroconidium-spheruleendospore transformation in Coccidioides immitis. In: Szaniszlo PJ (ed) Fungal dimorphism: with emphasis on fungi pathogenic for humans. Plenum, New York, pp 281–333
Cole GT, Seshan KR, Franco M, Bukownik E, Sun SH, Hearn VM (1988) Isolation and morphology of an immunoreactive outer wall fraction produced by spherules of Coccidioides immitis [published erratum appears in Infect Immun 1988 Dec;56(12):3334]. Infect Immun 56:2686–2694
Converse JL (1955) Growth of spherules of Coccidioides immitis in a chemically defined liquid medium. Proc Soc Exp Biol Med 90:709–711
Converse JL, Castleberry MW, Snyder EM (1963) Experimental viable vaccine against pulmonary coccidioidomycosis in monkeys. J Bact 86:1041–1051
Converse JL, Deauville GA, Snyder EM, Ray JG, Seaquist ME (1965) Control of tissue reactions in monkeys vaccinated with viable Coccidioides immitis by prevaccination with killed Coccidioides immitis. J Bact 90: 783–788
Corry DB, Ampel NM, Christian L, Locksley RM, Galgiani JN (1996) Cytokine production by peripheral blood mononuclear cells in human coccidioidomycosis. J Infect Dis 174:440–443
Cox RA (1989) Antigenic structure of Coccidioides immitis. Immunol Ser 47:133–170
Cox RA, Britt LA (1985) Antigenic heterogeneity of an alkali-soluble, water-soluble cell wall extract of Coccidioides immitis. Infect Immun 50:365–369
Cox RA, Magee DM (1995) Production of tumor necrosis factor alpha, interleukin-1 alpha, and interleukin-6 during murine coccidioidomycosis. Infect Immun 63:4178–4180
Cox RA, Magee DM (1998) Protective immunity in coccidioidomycosis. Res Immunol 149:417–428; discussion 506–507
Cox RA, Vivas JR (1977) Spectrum of in vivo and in vitro cell-mediated immune responses in coccidioidomycosis. Cell Immunol 31:130–141
Cox RA, Huppert M, Starr P, Britt LA (1984) Reactivity of alkali-soluble, water-soluble cell wall antigen of Coccidioides immitis with anti-Coccidioides immunoglobulin M precipitin antibody. Infect Immun 43:502–507
Cox RA, Kennell W, Boncyk L, Murphy JW (1988) Induction and expression of cell-mediated immune responses in inbred mice infected with Coccidioides immitis. Infect Immun 56:13–17
Cox RA, Dolan MJ, Magee DM, Galgiani JN (1993) Production of a murine monoclonal antibody that recognizes an epitope specific to Coccidioides immitis antigen 2. Infect Immun 61:1895–1899
Dickson EC (1937) Coccidioides infection. Arch Intern Med 59:1029–1044
Dooley DP, Cox RA, Hestilow KL, Dolan MJ, Magee DM (1994) Cytokine induction in human coccidioidomycosis. Infect Immun 62:3980–3983
Dugger KO, Galgiani JN, Ampel NM, Sun SH, Magee DM, Harrison J, Law JH (1991) An immunoreactive apoglycoprotein purified from Coccidioides immitis. Infect Immun 59:2245–2251
Dugger KO, Villareal KM, Ngyuen A, Zimmermann CR, Law JH, Galgiani JN (1996) Cloning and sequence analysis of the cDNA for a protein from Coccidioides immitis with immunogenic potential. Biochem Biophys Res Commun 218:485–489
Fisher MC, White TJ, Taylor JW (1999) Primers for genotyping single nucleotide polymorphisms and microsatellites in the pathogenic fungus Coccidioides immitis. Mol Ecol 8:1082–1084
Fisher MC, Koenig G, White TJ, Taylor JW (2000) A test for concordance between the multilocus genealogies of genes and microsatellites in the pathogenic fungus Coccidioides immitis. Mol Biol Evol 17:1164–1174
Fisher MC, Koenig G, White TJ, Taylor JW (2002) Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidoides immitis. Mycologia 94:73–84
Frey CL, Drutz DJ (1986) Influence of fungal surface components on the interaction of Coccidioides immitis with polymorphonuclear neutrophils. J Infect Dis 153: 933–943
Friedman L, Smith CE (1956) Vaccination of mice against Coccidioides immitis. Am Rev Tuber Pul Dis 74: 245–248
Galgiani JN (1993) Coccidioidomycosis. West J Med 159: 153–171
Hung CY, Ampel NM, Christian L, Seshan KR, Cole GT (2000) A major cell surface antigen of Coccidioides immitis which elicits both humoral and cellular immune responses. Infect Immun 68:584–593
Hung CY, Yu JJ, Seshan KR, Reichard U, Cole GT (2002) A parasitic phase-specific adhesin of Coccidioides immitis contributes to the virulence of this respiratory fungal pathogen. Infect Immun 70:3443–3456
Huppert M, Levine HB, Sun SH, Peterson ET (1967) Resistance of vaccinated mice to typical and atypical strains of Coccidioides immitis. J Bacteriol 94:924–927
Jiang C, Magee DM, Cox RA (1999a) Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis. Infect Immun 67:5848–5853
Jiang C, Magee DM, Quitugua TN, Cox RA (1999b) Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 CDNA. Infect Immun 67:630–635
Jiang C, Magee DM, Ivey FD, Cox RA (2002) Role of signal sequence in vaccine-induced protection against experimental coccidioidomycosis. Infect Immun 70: 3539–3545
Johnson SM, Kerekes KM, Zimmermann CR, Williams RH, Pappagianis D (2000) Identification and cloning of an aspartyl proteinase from Coccidioides immitis. Gene 241:213–222
Kirkland T, Cole GT (2002) Coccidioidomycosis: pathogenesis, immune response, and vaccine development. In: Calderone RA, Cihlar RL (eds) Fungal pathogenesis: principles and clinical applications. Marcel Dekker, New York, pp 365–400
Kirkland TN, Fierer J (1983) Inbred mouse strains differ in resistance to lethal Coccidioides immitis infection. Infect Immun 40:912–916
Kirkland TN, Fierer J (1985) Genetic control of resistance to Coccidioides immitis: a single gene that is expressed in spleen cells determines resistance. J Immunol 135: 548–552
Kirkland TN, Finley F, Orsborn KI, Galgiani JN (1998) Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in mice. Infect Immun 66:3519–3522
Kolivras KN, Johnson P, Comrie AC, Yool SR (2001) Environmental variability and coccidioidomycosis (Valley Fever). Aerobiologia 17:31–42
Kong YC, Levine HB, Smith CE (1963) Immunogenic properties of nondisrupted and disrupted spherules of Coccidioides immitis in mice. Sabouraudia 2:131–142
Lecara G, Cox RA, Simpson RB (1983) Coccidioides immitis vaccine: potential of an alkali-soluble, water-soluble cell wall antigen. Infect Immun 39:473–475
Levine HB, Cobb JM, Smith CE (1960) Immunity to coccidioidomycosis induced in mice by purified spherule, arthrospore, and mycelial vaccines. Trans NY Acad Sci 22:436–449
Levine HB, Cobb JM, Smith CE (1961) Immunogenicity of spherule-endospore vaccines of Coccidioides immitis for mice. J Immun 87:218–227
Levine HB, Miller RL, Smith CE (1962) Influence of vaccination on respiratory coccidioidal disease in cynomologous monkeys. J Immunol 89:242–251
Levine HB, Pappagianis D, Cobb JM (1970) Development of vaccines for coccidioidomycosis. Mycopathol Mycol App1 41:177–185
Li K, Yu JJ, Hung CY, Lehmann PF, Cole GT (2001) Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice. Infect Immun 69:2878–2887
Magee DM, Cox RA (1995) Roles of gamma interferon and interleukin-4 in genetically determined resistance to Coccidioides immitis. Infect Immun 63:3514–3519
Magee DM, Cox RA (1996) Interleukin-12 regulation of host defenses against Coccidioides immitis. Infect Immun 64:3609–3613
Mirbod F, Schaller RA, Cole GT (2002) Purification and characterization of urease isolated from the pathogenic fungus Coccidioides immitis. Med Mycol 40: 35–44
Murphy JW (1996) Cell-mediated immunity. In: Howard DH, Miller JD (eds) The Mycota. vol VI. Springer, Berlin Heidelberg New York, pp 67–98
Olson PE, Bone WD, LaBarre RC, Martin CR, Utz GC, Miller LK, Gresham L (1995) Coccidioidomycosis in California: regional outbreak, global diagnostic challenge. Mil Med 160:304–308
Ophuls W, Moffitt HC (1900) A new pathogenic mould (formerly described as a protozoon: Coccidioides immitis pyogenes) preliminary report. Philadelphia Med J 5: 1471–1472
Pappagianis D (1993a) Coccidioidomycosis. Semin Dermatol 12:301–309
Pappagianis D (1993b) Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever vaccine study group. Am Rev Respir Dis 148:656–660
Pappagianis D (1999) Coccidioides immitis antigen. J Infect Dis 180:243–244
Pappagianis D (2001a) Seeking a vaccine against Coccidioides immitis and serologic studies: expectations and realities. Fungal Genet Biol 32:1–329
Pappagianis D (2001b) Serologic studies in coccidioidomycosis. Semin Respir Infect 16:242–250
Pappagianis D, Levine HB (1975) The present status of vaccination against coccidioidomycosis in man. Am J Epidemiol 102:30–41
Pappagianis D, Zimmer BL (1990) Serology of coccidioidomycosis. Clin Microbiol Rev 3:247–268
Pappagianis D, Levine HB, Smith CE (1967) Further studies on vaccination of human volunteers with killed Coccidioides immitis. In: Ajello L (ed) Coccidioidomycosis. The University of Arizona Press, Tucson, pp 201–210
Pappagianis D, Miller RL, Smith CE, Kobayashi GS (1960) Response of monkeys to respiratory challenge following subcutaneous inoculation with Coccidioides immitis. Am Rev Resp Dis 82:244–250
Pappagianis D, Levine HB, Smith CE, Berman RJ, Kobayashi GK (1961) Immunization of mice with viable Coccidioides immitis. J Immunol 86:28–34
Peng T, Orsborn KI, Orbach MJ, Galgiani JN (1999) Prolinerich vaccine candidate antigen of Coccidioides immitis: conservation among isolates and differential expression with spherule maturation. J Infect Dis 179: 518–521
Peng T, Shubitz L, Simons J, Perrill R, Orsborn KI, Galgiani JN (2002) Localization within a proline-rich antigen (Ag2/PRA) of protective antigenicity against infection with Coccidioides immitis in mice. Infect Immun 70: 3330–3335
Posadas A (1892) Ensayo anatomopatologico sobre una neoplasia considereda como micosis fungoidea. An Circ Med Argent 15:8–11
Richards JO, Ampel NM, Lake DF (2002) Reversal of coccidioidal anergy in vitro by dendritic cells from patients with disseminated coccidioidomycosis. J Immunol 169:2020–2025
Rixford E, Gilchrist TC (1896) Two cases of protozoan (coccidioidal) infection of the skin and other organs. Johns Hopkins Hospital Rev 1:209–268
Shubitz L, Peng T, Perrill R, Simons J, Orsborn K, Galgiani JN (2002) Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2/PRA. Infect Immun 70: 3287–3289
Smith CE (1943) Coccidioidomycosis. M Clin North Am 27: 790–807
Smith CE (1948) The use of coccidioidin. Am Rev Tuberc 57:330–360
Vogel RA, Fetter BF, Conant NF, Lowe EP (1954) Preliminary studies on artificial active immunization of guinea pigs against respiratory challenge with Coccidioides immitis. Am Rev Tuberc 70:498–503
Ward ER, Cox RA, Schmitt JA, Huppert M, Sun SH (1975) Delayed-type hypersensitivity responses to a cell wall fraction of the mycelial phase of Coccidioides immitis. Infect Immun 12:1093–1097
Williams PL (1984) Further assessment of the morbidity associated with the killed Coccidioides immitis spherule vaccine in humans. In: Einstein H, Catanzaro A (eds) Coccidioidomycosis: proceedings of the 4th international conference. The National Foundation for Infectious Disease, Washington, pp 339–346
Yu JJ, Smithson SL, Thomas PW, Kirkland TN, Cole GT (1997) Isolation and characterization of the urease gene (URE) from the pathogenic fungus Coccidioides immitis. Gene 198:387–391
Zhu Y, Yang C, Magee DM, Cox RA (1996a) Coccidioides immitis antigen 2: analysis of gene and protein. Gene 181:121–125
Zhu Y, Yang C, Magee DM, Cox RA (1996b) Molecular cloning and characterization of Coccidioides immitis antigen 2 cDNA. Infect Immun 64:2695–2699
Zhu Y, Tryon V, Magee DM, Cox RA (1997) Identification of a Coccidioides immitis antigen 2 domain that expresses B-cell-reactive epitopes. Infect Immun 65: 3376–3380
Zimmermann CR, Snedker CJ, Pappagianis D (1994) Characterization of Coccidioides immitis isolates by restriction fragment length polymorphisms. J Clin Microbiol 32:3040–3042
Zimmermann CR, Johnson SM, Martens GW, White AG, Zimmer BL, Pappagianis D (1998) Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules. Infect Immun 66:2342–2345
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Magee, D.M., Cox, R.A. (2004). Vaccine Development for Coccidioidomycosis. In: Domer, J.E., Kobayashi, G.S. (eds) Human Fungal Pathogens. The Mycota, vol 12. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10380-7_13
Download citation
DOI: https://doi.org/10.1007/978-3-662-10380-7_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-07651-0
Online ISBN: 978-3-662-10380-7
eBook Packages: Springer Book Archive